Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2022 Financial Results

Rhea-AI Summary

Artivion, Inc. (NYSE: AORT) has announced that its third quarter 2022 financial results will be released on November 3, 2022, after market close. A teleconference will follow at 4:30 p.m. ET to discuss the results, led by Pat Mackin, the company's CEO. Investors can access the live webcast and replay on Artivion's website.

The company specializes in cardiac and vascular solutions for aortic diseases and sells products in over 100 countries worldwide.

ATLANTA, Oct. 20, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2022 financial results will be released on Thursday, November 3, 2022 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question and answer session hosted by Pat Mackin, Chairman, President and Chief Executive Officer of Artivion.

To listen to the live teleconference, please dial 862-298-0702 a few minutes prior to 4:30 p.m. ET. The teleconference replay will be available approximately one hour following the completion of the event and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415. The conference number for the replay is 13733812. 

The live webcast and replay can be accessed on the Investors section of the Artivion website at www.artivion.com and by selecting Webcasts & Presentations. In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investors section of the Artivion website.

About Artivion, Inc.

Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.

Contacts: 

Artivion	Gilmartin Group LLC
D. Ashley Lee	Brian Johnston / Lynn Lewis
Executive Vice President &	Phone: 332-895-3222
Chief Financial Officer	investors@artivion.com
Phone: 770-419-3355

View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-announces-release-date-and-teleconference-call-details-for-third-quarter-2022-financial-results-301654522.html

SOURCE Artivion, Inc.

FAQ

When will Artivion release its third quarter 2022 financial results?

Artivion will release its third quarter 2022 financial results on November 3, 2022, after market close.

What time is the teleconference for Artivion's third quarter financial results?

The teleconference will be held at 4:30 p.m. ET on November 3, 2022.

Who will lead the teleconference call for Artivion's earnings release?

The teleconference call will be led by Pat Mackin, Chairman, President and CEO of Artivion.

Where can I access the webcast for Artivion's third quarter financial results?

The live webcast for Artivion's financial results can be accessed on their Investors section of the website.